Download presentation
Presentation is loading. Please wait.
Published byHollie Cooper Modified over 6 years ago
1
Double-Blind Placebo-Controlled Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria Matt Morgan, MD, Andrew Cooke, MD, Laura Rogers, MD, Beverley Adams-Huet, MS, David A. Khan, MD The Journal of Allergy and Clinical Immunology: In Practice Volume 2, Issue 5, Pages (September 2014) DOI: /j.jaip Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions
2
Figure 1 Study design. The Journal of Allergy and Clinical Immunology: In Practice 2014 2, DOI: ( /j.jaip ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions
3
Figure 2 Study flow diagram.
The Journal of Allergy and Clinical Immunology: In Practice 2014 2, DOI: ( /j.jaip ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions
4
Figure 3 Treatment-order interaction shown for WIS over 14 weeks. Dapsone (filled symbols), placebo (open symbols). The Journal of Allergy and Clinical Immunology: In Practice 2014 2, DOI: ( /j.jaip ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions
5
Figure 4 Dapsone vs placebo in WHS over time. Dapsone (filled symbols), placebo (open symbols). The Journal of Allergy and Clinical Immunology: In Practice 2014 2, DOI: ( /j.jaip ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions
6
Figure 5 Dapsone vs placebo in WIS over time. Dapsone (filled symbols), placebo (open symbols). The Journal of Allergy and Clinical Immunology: In Practice 2014 2, DOI: ( /j.jaip ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com Inc.
All rights reserved.